Tessera Technologies, Inc. (Nasdaq:TSRA) announced its results for the
third quarter ended Sept. 30, 2009.
Revenue Highlights: Third Quarter 2009
-
Total revenues were $66.1 million.
-
Micro-electronics revenue was $59.1 million.
-
Imaging & Optics revenue was $7.0 million.
Third quarter 2009 Micro-electronics revenue was comprised entirely of
Royalties and License Fees. Imaging & Optics revenue was comprised of
$3.7 million in Royalties and License Fees, and $3.3 million in Products
and Services.
Generally accepted accounting principles (GAAP) net income for the third
quarter of 2009 was $12.1 million, or $0.24 per diluted share, which
included non-cash charges of $6.9 million for stock-based compensation
and $3.0 million for amortization of acquired intangibles.
Non-GAAP net income for the third quarter of 2009 was $19.2 million or
$0.37 per diluted share. Non-GAAP net income is defined as income and
operating expenses adjusted for acquired intangibles amortization,
charges for acquired in-process research and development, stock-based
compensation expense, and related tax effects.
"Better than anticipated results from our Micro-electronics customers
drove our third quarter 2009 revenue to $66.1 million,” said Henry R.
Nothhaft, president and chief executive officer, Tessera. "Roughly 60%
of DRAM sold today is in the DDR2 format. DDR3, also packaged in our
patented chip-scale packaging technology, is expected to become the
primary DRAM format by mid-2010. Due to improvements in speed and
performance, it is anticipated DDR3 will remain the primary format
through at least 2013. Tessera is well positioned to benefit from this
transition and the long-term growth of the DRAM market, which we expect
will drive growth in our Micro-electronics business. With respect to our
Imaging & Optics business, we signed three new licensing agreements in
the third quarter, for technologies ranging from our Wafer-level
Packaging to Optical and Embedded Image Enhancement, and expect them to
further drive our Imaging & Optics royalty revenue growth in 2010. We
continue to expand our research and development resources that are
focused on Wafer-level Camera and Silent Air Cooling.”
Revenue Highlights: Nine-month Period Ended Sept. 30, 2009
-
Total revenue was $243.0 million.
-
Micro-electronics revenue was $221.3 million.
-
Imaging & Optics revenue was $21.7 million.
Micro-electronics revenue for the nine-month period ended Sept. 30, 2009
was comprised of $221.2 million in Royalties and License Fees, and
$48,000 in Products and Services. Imaging & Optics revenue for the
nine-month period ended Sept. 30, 2009 was comprised of $13.3 million in
Royalties and License Fees, and $8.4 million in Products and Services.
GAAP net income for the nine-month period was $63.4 million, or $1.30
per diluted share. Non-GAAP net income for the nine-month period was
$85.5 million, or $1.71 per diluted share.
Fourth Quarter 2009 Financial Guidance
Fourth quarter 2009 total revenues are expected to range between $60.0
million and $62.0 million. This compares to fourth quarter 2008 total
revenues of $69.1 million, which included a non-recurring option fee
paid by Motorola, Inc.
Fourth quarter 2009 Micro-electronics revenue is expected to range
between $53.0 million and $54.0 million, all of which will be royalty
and license related. Tessera has two major DRAM customers with
volume-based pricing incentives that will reduce the company’s revenue
sequentially in the fourth quarter 2009. As a reminder, Tessera
recognizes revenue one quarter in arrears.
As a comparison, in the fourth quarter of 2008, Micro-electronics
royalty and license fees revenue was $58.9 million and included the
non-recurring option fee paid by Motorola, Inc. Products and services
revenue was $872,000 and past production payments were $170,000, for a
total of $59.9 million for this segment.
Fourth quarter 2009 Imaging & Optics revenue, in total, is expected to
be between $7.0 million and $8.0 million. Imaging & Optics royalty and
license fees revenue is expected to range from $3.0 million to $4.0
million. Imaging & Optics products and services revenue is expected to
be $4.0 million. This compares to Imaging & Optics royalty and license
fees revenue of $3.6 million and products and services revenue of $5.6
million in the fourth quarter of 2008, which totaled $9.2 million for
this segment. The products and services revenue is down year-over-year
primarily due to the slowdown in the semiconductor equipment market.
Non-GAAP operating expenses for the fourth quarter of 2009 are projected
to range between $30.0 million and $31.0 million, excluding litigation
expenses.
Conference Call Information
Tessera will hold its third quarter 2009 earnings conference call at
1:30 P.M. Pacific (4:30 P.M. Eastern) today. To access the call in the
U.S., please dial 866-531-1286, and for international callers dial
706-643-3789 approximately 10 minutes prior to the start of the
conference call. The conference call will also be broadcast live over
the Internet and available for replay for 90 days at www.tessera.com.
In addition, a replay of the call will be available via telephone for
two business days, beginning two hours after the call. To listen to the
telephone replay in the U.S., please dial 800-642-1687 and for
international callers, dial 706-645-9291. Enter access code 34561594.
Safe Harbor Statement
This press release contains forward-looking statements, which are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements involve risks
and uncertainties that could cause actual results to differ
significantly from those projected, particularly with respect to the
company’s financial results, industry and technology trends, and the
company’s IP protection efforts, including litigation. Material factors
that may cause results to differ from the statements made include
delays, setbacks or losses relating to our intellectual property or
intellectual property litigations, or any invalidation or limitation of
our key patents; fluctuations in our operating results due to the timing
of new license agreements and royalties, or due to legal costs; changes
in patent laws, regulation or enforcement, or other factors that might
affect our ability to protect our intellectual property; the risk of a
decline in demand for semiconductor products; failure by the industry to
adopt our technologies; competing technologies; the future expiration of
our patents; the future expiration of our license agreements and the
cessation of related royalty income; the failure or refusal of licensees
to pay royalties; failure to achieve the growth prospects and synergies
expected from acquisition transactions; and delays and challenges
associated with integrating acquired companies with our existing
businesses. You are cautioned not to place undue reliance on the
forward-looking statements, which speak only as of the date of this
release. Tessera’s filings with the Securities and Exchange Commission,
including its Annual Report on Form 10-K for the year ended December 31,
2008 and its Quarterly Report on Form 10-Q for the quarter ended June
30, 2009, include more information about factors that could affect the
company's financial results. Tessera assumes no obligation to update
information contained in this press release. Although this release may
remain available on Tessera's website or elsewhere, its continued
availability does not indicate that Tessera is reaffirming or confirming
any of the information contained herein.
About Tessera
Tessera Technologies, Inc. invests in, licenses and delivers innovative
miniaturization technologies for next-generation electronic devices. The
company’s micro-electronics solutions enable smaller,
higher-functionality devices through chip-scale, 3D and wafer-level
packaging technology, as well as high-density substrate and silent air
cooling technology. Tessera’s imaging and optics solutions provide
low-cost, high-quality camera functionality in electronic products and
include image sensor packaging, wafer-level optics and image enhancement
intellectual property. The company also offers customized micro-optic
lenses, from diffractive and refractive optical elements to integrated
micro-optical subassemblies. Tessera licenses its technologies, as well
as delivers products based on these technologies, to promote the
development of the supply chain infrastructure. The company is
headquartered in San Jose, California. For information call
1.408.321.6000 or go to www.tessera.com.
Non-GAAP Financial Measures
In addition to disclosing financial results calculated in accordance
with U.S. generally accepted accounting principles (GAAP), the company’s
earnings release contains non-GAAP financial measures adjusted for
either one-time or ongoing non-cash acquired intangibles amortization
charges, acquired in-process research and development, all forms of
stock-based compensation, and related tax effects. The non-GAAP
financial measures also exclude the effects of FAS 123R upon the number
of diluted shares used in calculating non-GAAP earnings per share.
Management believes that the non-GAAP measures used in this report
provide investors with important perspectives into the company’s ongoing
business performance. The non-GAAP financial measures disclosed by the
company should not be considered a substitute for, or superior to,
financial measures calculated in accordance with GAAP, and the financial
results calculated in accordance with GAAP and reconciliations to those
financial statements should be carefully evaluated. The non-GAAP
financial measures used by the company may be calculated differently
from, and therefore may not be comparable to, similarly titled measures
used by other companies.
Set forth below are reconciliations of non-GAAP net income to Tessera’s
reported GAAP net income.
Tessera and the Tessera logo are trademarks or registered trademarks of
Tessera, Inc. or its affiliated companies in the United States and other
countries. All other company, brand and product names may be trademarks
or registered trademarks of their respective companies.
|
|
|
|
|
TESSERA TECHNOLOGIES, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
(in thousands, except per share amounts)
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
|
|
|
|
September 30,
|
|
September 30,
|
|
|
|
|
|
|
2009
|
|
|
2008
|
|
|
|
2009
|
|
|
2008
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
Royalty and license fees
|
|
$
|
62,743
|
|
$
|
57,587
|
|
|
$
|
234,470
|
|
$
|
157,771
|
|
|
|
Product and service revenues
|
|
|
3,380
|
|
|
5,914
|
|
|
|
8,500
|
|
|
21,395
|
|
|
|
|
Total revenues
|
|
|
66,123
|
|
|
63,501
|
|
|
|
242,970
|
|
|
179,166
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
Cost of revenues
|
|
|
3,941
|
|
|
4,074
|
|
|
|
11,941
|
|
|
12,801
|
|
|
|
Research, development and other related costs
|
|
|
16,780
|
|
|
15,898
|
|
|
|
50,259
|
|
|
44,945
|
|
|
|
Selling, general and administrative
|
|
|
19,455
|
|
|
17,866
|
|
|
|
54,233
|
|
|
50,775
|
|
|
|
Litigation expense
|
|
|
6,066
|
|
|
29,217
|
|
|
|
20,229
|
|
|
66,567
|
|
|
|
|
Total operating expenses
|
|
|
46,242
|
|
|
67,055
|
|
|
|
136,662
|
|
|
175,088
|
|
|
Operating income (loss)
|
|
|
19,881
|
|
|
(3,554
|
)
|
|
|
106,308
|
|
|
4,078
|
|
|
Other income and expense, net
|
|
|
590
|
|
|
(1,033
|
)
|
|
|
4,448
|
|
|
3,280
|
|
|
Income (loss) before taxes
|
|
|
20,471
|
|
|
(4,587
|
)
|
|
|
110,756
|
|
|
7,358
|
|
|
Provision for income taxes
|
|
|
8,337
|
|
|
770
|
|
|
|
47,317
|
|
|
10,405
|
|
|
Net income (loss)
|
|
$
|
12,134
|
|
$
|
(5,357
|
)
|
|
$
|
63,439
|
|
$
|
(3,047
|
)
|
|
Basic and diluted net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share - basic
|
|
$
|
0.25
|
|
$
|
(0.11
|
)
|
|
$
|
1.31
|
|
$
|
(0.06
|
)
|
|
|
Net income (loss) per share - diluted
|
|
$
|
0.24
|
|
$
|
(0.11
|
)
|
|
$
|
1.30
|
|
$
|
(0.06
|
)
|
|
|
Weighted average number of shares used in per share calculations -
basic
|
|
|
49,201
|
|
|
47,904
|
|
|
|
48,598
|
|
|
47,951
|
|
|
|
Weighted average number of shares used in per share calculations -
diluted
|
|
|
49,862
|
|
|
47,904
|
|
|
|
48,981
|
|
|
47,951
|
|
|
TESSERA TECHNOLOGIES, INC.
|
|
|
|
|
|
|
|
|
|
|
CONSOLIDATED BALANCE SHEETS
|
|
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
|
|
December 31,
|
|
|
|
|
|
|
|
2009
|
|
|
2008*
|
|
|
|
|
|
|
(unaudited)
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
160,412
|
|
|
$
|
87,890
|
|
|
|
Short-term investments
|
|
|
217,946
|
|
|
|
188,610
|
|
|
|
Accounts receivable, net
|
|
|
13,651
|
|
|
|
14,724
|
|
|
|
Inventories
|
|
|
|
1,341
|
|
|
|
1,534
|
|
|
|
Deferred tax assets
|
|
|
2,836
|
|
|
|
2,409
|
|
|
|
Other current assets
|
|
|
5,131
|
|
|
|
8,220
|
|
|
|
|
|
Total current assets
|
|
|
401,317
|
|
|
|
303,387
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
|
42,429
|
|
|
|
36,984
|
|
|
Intangible assets, net
|
|
|
75,214
|
|
|
|
71,312
|
|
|
Goodwill
|
|
|
|
|
45,150
|
|
|
|
40,444
|
|
|
Deferred tax assets
|
|
|
19,227
|
|
|
|
19,756
|
|
|
Long-term investments
|
|
|
18,714
|
|
|
|
22,134
|
|
|
Other assets
|
|
|
|
4,017
|
|
|
|
7,572
|
|
|
|
|
|
Total assets
|
|
$
|
606,068
|
|
|
$
|
501,589
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
3,523
|
|
|
$
|
2,924
|
|
|
|
Accrued legal fees
|
|
|
6,526
|
|
|
|
13,945
|
|
|
|
Accrued liabilities
|
|
|
18,416
|
|
|
|
17,747
|
|
|
|
Deferred revenue
|
|
|
6,639
|
|
|
|
6,085
|
|
|
|
Income tax payable
|
|
|
12
|
|
|
|
1,385
|
|
|
|
|
|
Total current liabilities
|
|
|
35,116
|
|
|
|
42,086
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilities
|
|
|
8,991
|
|
|
|
8,991
|
|
|
|
Other long-term liabilities
|
|
|
4,208
|
|
|
|
3,608
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity:
|
|
|
|
|
|
|
Common stock
|
|
|
50
|
|
|
|
49
|
|
|
|
Additional paid-in capital
|
|
|
394,229
|
|
|
|
347,568
|
|
|
|
Treasury stock
|
|
|
(10,505
|
)
|
|
|
(10,505
|
)
|
|
|
Accumulated other comprehensive loss
|
|
|
(29
|
)
|
|
|
(777
|
)
|
|
|
Retained earnings
|
|
|
174,008
|
|
|
|
110,569
|
|
|
|
|
|
Total stockholders' equity
|
|
|
557,753
|
|
|
|
446,904
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders' equity
|
|
$
|
606,068
|
|
|
$
|
501,589
|
|
|
|
|
|
|
|
|
|
|
|
* Derived from audited financial statements
|
|
|
|
|
|
|
|
TESSERA TECHNOLOGIES, INC.
|
|
|
|
|
|
|
|
RECONCILIATION TO NON-GAAP INCOME FROM GAAP NET INCOME
|
|
|
|
(in thousands, except per share amounts)
|
|
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
|
|
|
|
September 30,
|
|
September 30,
|
|
|
|
|
|
|
2009
|
|
|
|
2008
|
|
|
|
2009
|
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net income (loss)
|
|
$
|
12,134
|
|
|
$
|
(5,357
|
)
|
|
$
|
63,439
|
|
|
$
|
(3,047
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments to GAAP net income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation - cost of revenues
|
|
|
199
|
|
|
|
92
|
|
|
|
450
|
|
|
|
345
|
|
|
|
|
Stock-based compensation - research, development and other related
costs
|
|
|
2,379
|
|
|
|
2,457
|
|
|
|
8,489
|
|
|
|
5,571
|
|
|
|
|
Stock-based compensation - selling, general and administrative
|
|
|
4,312
|
|
|
|
4,046
|
|
|
|
11,498
|
|
|
|
10,966
|
|
|
|
|
Amortization of acquired intangibles - cost of revenues
|
|
|
1,705
|
|
|
|
766
|
|
|
|
5,115
|
|
|
|
2,126
|
|
|
|
|
Amortization of acquired intangibles - research, development and
other related costs
|
|
|
642
|
|
|
|
1,677
|
|
|
|
2,021
|
|
|
|
4,777
|
|
|
|
|
Amortization of acquired intangibles - selling, general and
administrative
|
|
|
685
|
|
|
|
459
|
|
|
|
1,673
|
|
|
|
1,249
|
|
|
|
|
Tax adjustments for non-GAAP items
|
|
|
(2,896
|
)
|
|
|
(1,803
|
)
|
|
|
(7,218
|
)
|
|
|
(4,300
|
)
|
|
|
|
Adjustment for acquired in-process research & development charge
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP net income
|
|
$
|
19,160
|
|
|
$
|
2,337
|
|
|
$
|
85,467
|
|
|
$
|
20,187
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP net income per common share - diluted
|
|
$
|
0.37
|
|
|
$
|
0.05
|
|
|
$
|
1.71
|
|
|
$
|
0.41
|
|
|
Weighted average number of shares used in per share calculations
excluding the effects of FAS 123R - diluted
|
|
|
51,326
|
|
|
|
49,154
|
|
|
|
49,889
|
|
|
|
49,277
|
|
|
TESSERA TECHNOLOGIES, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONSOLIDATED REVENUE DETAILS
|
|
(in thousands)
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
|
|
|
|
September 30,
|
|
September 30,
|
|
|
|
|
|
|
2009
|
|
|
2008
|
|
|
2009
|
|
|
2008
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
Micro-Electronics
|
|
|
|
|
|
|
|
|
|
|
|
Royalty and license fees
|
|
$
|
59,060
|
|
$
|
56,035
|
|
$
|
221,199
|
|
$
|
150,858
|
|
|
|
Product and service revenues
|
|
|
3
|
|
|
554
|
|
|
48
|
|
|
3,775
|
|
|
|
Total Micro-Electronics revenues
|
|
|
59,063
|
|
|
56,589
|
|
|
221,247
|
|
|
154,633
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Imaging and Optics
|
|
|
|
|
|
|
|
|
|
|
|
Royalty and license fees
|
|
|
3,684
|
|
|
1,552
|
|
|
13,271
|
|
|
6,913
|
|
|
|
Product and service revenues
|
|
|
3,376
|
|
|
5,360
|
|
|
8,452
|
|
|
17,620
|
|
|
|
Total Imaging and Optics revenues
|
|
|
7,060
|
|
|
6,912
|
|
|
21,723
|
|
|
24,533
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
$
|
66,123
|
|
$
|
63,501
|
|
$
|
242,970
|
|
$
|
179,166
|
TSRA-E